These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3067712)

  • 1. Monitoring of cardiac transplants with beta 2-microglobulin, cytoimmunological monitoring and endmyocardial biopsy: what's their value in detecting rejection?
    Semik M; Konertz W; Westphal E; Heusermann U; Friedl A; Bernhard A
    Bibl Cardiol; 1988; (43):133-6. PubMed ID: 3067712
    [No Abstract]   [Full Text] [Related]  

  • 2. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of beta 2-microglobulin in the monitoring of patients after orthotopic heart transplantation.
    Prischl F; Teufelsbauer H; Havel M; Laczkovics A; Wolner E; Schwarzmeier J
    Bibl Cardiol; 1988; (43):111-5. PubMed ID: 3067708
    [No Abstract]   [Full Text] [Related]  

  • 4. Noninvasive patient control after heart transplantation. A 6-year experience at the Munich University Hospital.
    Kemkes BM; Angermann C; Haberl R; Reichenspurner H; Klanke D; Anthuber M; Gokel M
    Bibl Cardiol; 1988; (43):119-27. PubMed ID: 3067710
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytoimmunological monitoring to detect rejection after heart transplantation.
    Jutte NH; Daane R; van den Bemd JM; Hop WC; Essed CE; Simoons ML; Bos E; Weimar W
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2519-20. PubMed ID: 2650319
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyto-immunologic monitoring following heart transplantation.
    Wijngaard PL; Heyn A; van der Meulen A; de Vries H
    Bibl Cardiol; 1988; (43):137-41. PubMed ID: 3067713
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytoimmunologic monitoring in early and late acute cardiac rejection.
    Fieguth HG; Haverich A; Schäfers HJ; Wahlers T; Herrmann G; Frimpong-Boateng K; Cremer J; Kemnitz J; Borst HG
    J Heart Transplant; 1988; 7(2):95-101. PubMed ID: 3284990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoimmunologic monitoring as an adjunct in monitoring rejection after heart transplantation: results of a 6-year follow-up in heart transplant recipients.
    Wijngaard PL; Doornewaard H; van der Meulen A; Plomp S; Gmelig Meyling FH; de Jonge N; Schuurman HJ
    J Heart Lung Transplant; 1994; 13(5):869-75. PubMed ID: 7803429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complications of endocardial biopsy in heart transplant patients].
    Uchida N; Mukai S; Wada S; Mitsui N; Sueda T; Matsuura Y; Hirai S; Baudet E
    Kyobu Geka; 1995 Jul; 48(7):557-9. PubMed ID: 7637221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart transplantation: life-long biopsies for prevention of rejection?].
    Stallmach T; Gaspert A; Ersch J; Oechslin E
    Schweiz Med Wochenschr; 2000 Jun; 130(25):957-62. PubMed ID: 10909723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 2 microglobulins in rejection and cytomegalovirus infection in a cardiac transplant recipient.
    Goldman MH; Landwehr DM; Lippman R; Hess M; Wolfgang T; Szentpetery S; Hastillo A; Mendez-Picon G; Lee HM; Lower RR
    Transplant Proc; 1982 Jun; 14(2):437-9. PubMed ID: 6180532
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytoimmunologic monitoring for the diagnosis of acute rejection after heart transplantation.
    Wijngaard PL; van der Meulen A; Schuurman HJ; Gmelig Meyling FH; Heyn A; Borleffs JC; Jambroes G
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2521-2. PubMed ID: 2650320
    [No Abstract]   [Full Text] [Related]  

  • 13. The diagnosis of acute cardiac rejection by endomyocardial biopsy.
    Billingham ME
    Bibl Cardiol; 1988; (43):83-102. PubMed ID: 3067725
    [No Abstract]   [Full Text] [Related]  

  • 14. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
    White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of endomyocardial biopsy in the diagnosis of lymphoproliferative disorder after heart transplantation.
    Fernández-González AL; Herreros-González JM; Pardo Mindán J
    J Heart Lung Transplant; 1994; 13(6):1146. PubMed ID: 7865524
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
    Webber SA; Bentlejewski C; Park A; Fricker FJ; Griffith C; Boyle GJ; Miller SA; Pham S; Murali S; Griffith BP; Duquesnoy R; Zeevi A
    Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical importance of grade 2 cellular heart rejection.
    el-Gamel A; Doran H; Rahman A; Deiraniya A; Campbell C; Yonan N
    J Heart Lung Transplant; 1996 Mar; 15(3):319-21. PubMed ID: 8777219
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring of heart allograft rejection by simultaneous measurement of serum beta 2-microglobulin and urinary neopterin.
    Schmitt F; Myara I; Benoit MO; Guillemain R; Amrein C; Dreyfus G; Paris M; Moatti N
    Ann Biol Clin (Paris); 1989; 47(5):237-41. PubMed ID: 2662838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring rejection after heart transplantation: cytoimmunological monitoring on blood cells and quantitative birefringence measurements on endomyocardial biopsy specimens.
    Wijngaard PL; Gimpel JA; Schuurman HJ; van der Meulen A; Gmelig Meyling FH; Jambroes G
    J Clin Pathol; 1990 Feb; 43(2):137-42. PubMed ID: 2318989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.
    van Gelder T; Mulder AH; Balk AH; Mochtar B; Hesse CJ; Baan CC; Vaessen LM; Weimar W
    J Heart Lung Transplant; 1995; 14(2):346-50. PubMed ID: 7779855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.